CRVO Earnings CervoMed Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–45 of 45
| Q2 2026 | 2026-06-30 | -0.64 | 2026-08-07 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.86 | 2026-05-15 | 10-Q |
| Q4 2025 (derived) | 2025-12-31 | -0.88 | 2026-03-13 | 10-K |
| FY 2025 | 2025-12-31 | -2.98 | 2026-03-13 | 10-K |
| Q3 2025 | 2025-09-30 | -0.84 | 2025-11-07 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.70 | 2025-08-08 | 10-Q |
| Q1 2025 | 2025-03-31 | -0.56 | 2025-05-12 | 10-Q |
| Q4 2024 (derived) | 2024-12-31 | -0.79 | 2025-03-17 | 10-K |
| FY 2024 | 2024-12-31 | -2.02 | 2025-03-17 | 10-K |
| Q3 2024 | 2024-09-30 | -0.55 | 2024-11-12 | 10-Q |
| Q2 2024 | 2024-06-30 | -0.27 | 2024-08-09 | 10-Q |
| Q1 2024 | 2024-03-31 | -0.41 | 2024-05-14 | 10-Q |
| Q4 2023 (derived) | 2023-12-31 | 2.31 | 2024-03-29 | 10-K |
| FY 2023 | 2023-12-31 | -0.82 | 2024-03-29 | 10-K |
| Q3 2023 | 2023-09-30 | -0.70 | 2023-11-13 | 10-Q |
| Q2 2023 | 2023-06-30 | -2.75 | 2023-08-08 | 10-Q |
| Q1 2023 | 2023-03-31 | -1.03 | 2023-05-15 | 10-Q |
| FY 2022 | 2022-12-31 | 2038891.00 | 2023-03-24 | 10-K |
| Q3 2022 | 2022-09-30 | -1.70 | — | — |
| Q4 2021 (derived) | 2021-12-31 | -3797703.84 | 2022-03-18 | 10-K |
| FY 2021 | 2021-12-31 | 1946859.00 | 2022-03-18 | 10-K |
| Q3 2021 | 2021-09-30 | 2038079.58 | 2021-11-10 | 10-Q |
| Q2 2021 | 2021-06-30 | 2038079.58 | 2021-08-11 | 10-Q |
| Q1 2021 | 2021-03-31 | 1668403.68 | 2021-05-07 | 10-Q |
| Q4 2020 (derived) | 2020-12-31 | -1933303.02 | 2021-03-17 | 10-K |
| FY 2020 | 2020-12-31 | 1076639.46 | 2021-03-17 | 10-K |
| Q3 2020 | 2020-09-30 | 1280226.84 | 2020-11-12 | 10-Q |
| Q2 2020 | 2020-06-30 | 1039565.72 | 2020-08-07 | 10-Q |
| Q1 2020 | 2020-03-31 | 690149.92 | 2020-05-11 | 10-Q |
| Q4 2019 (derived) | 2019-12-31 | -106073.90 | 2020-03-17 | 10-K |
| FY 2019 | 2019-12-31 | 134130.18 | 2020-03-17 | 10-K |
| Q3 2019 | 2019-09-30 | 93865.80 | 2019-11-08 | 10-Q |
| Q2 2019 | 2019-06-30 | 78813.68 | 2019-08-08 | 10-Q |
| Q1 2019 | 2019-03-31 | 67524.60 | 2019-05-09 | 10-Q |
| Q4 2018 (derived) | 2018-12-31 | -126265.06 | 2019-03-19 | 10-K |
| FY 2018 | 2018-12-31 | 64846.02 | 2019-03-19 | 10-K |
| Q3 2018 | 2018-09-30 | 67429.36 | 2018-11-13 | 10-Q |
| Q2 2018 | 2018-06-30 | 67395.40 | 2018-08-10 | 10-Q |
| Q1 2018 | 2018-03-31 | 56286.32 | — | — |
| FY 2017 | 2017-12-31 | -0.58 | 2018-04-02 | 10-K |
| Q3 2017 | 2017-09-30 | 0.06 | 2017-11-13 | 10-Q |
| Q2 2017 | 2017-06-30 | -0.30 | 2017-08-14 | 10-Q |
| FY 2016 | 2016-12-31 | -0.53 | — | — |
| Q3 2016 | 2016-09-30 | -0.16 | — | — |
| Q2 2016 | 2016-06-30 | -0.11 | — | — |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.